Table 2.
Summary of Reported Antibody Complex Structures for Protoparvoviruses and Erythroparvoviruses
Virus | Antibody/Fab | Resolution in Å | Involved VRs | Contact residues | Reference |
---|---|---|---|---|---|
Protoparvovirus | |||||
MVM1 | B7 | 7 | 2, 4b | 225, 228, 229, 425, 426, 432–440 | Kaufmann et al. (66) |
FPV | Fab6 | 18 | 0, 2, 4b, 5 | 92, 93, 219, 226, 421, 425–428, 433, 435, 437, 438, 440, | Hafenstein et al. (53) |
Fab-8 | 8.5 | 0, 2, 6, 7, 8 | 81, 85, 87, 296–299, 301, 302, 510–517 | Hafenstein et al. (53) | |
Fab-15 | 10.5 | 0, 2, 6, 7, 8 | 81, 292–299, 300–302, 305, 306, 515–517, 570, 559 | Hafenstein et al. (53) | |
Fab-16 | 13 | 0, 2, 6, 7, 8 | 75, 292, 293, 295–299, 300–303, 305, 386, 387, 389–391, 516, 517, 520, 570 | Hafenstein et al. (53) | |
Fab-B | 14 | 0, 2, 4b, 5 | 91–93, 219, 226, 227, 228, 421, 425–428, 440, | Hafenstein et al. (53) | |
Fab-E | 12 | 0, 2, 8 | 87, 88, 231, 233, 234, 298, 299, 300–302, 387, 556 | Hafenstein et al., (53) | |
Fab-F | 14 | 0, 2, 8 | 87, 228, 231, 234, 236, 298, 299, 300–302, 387 | Hafenstein et al., (53) | |
CPV | Fab-E | 4.1 | 0, 2, 3, 8 | 81, 85, 87, 88, 91, 101, 123, 231–237, 387, 390, 391, 554–565, 568, 570 | Organtini et al. (91) |
Fab-14 | 12.4 | 2, 4b, 5 | 87, 88, 89, 91, 93, 95, 222, 223, 224, 227, 305, 309, 312, 324, 422, 423, 425–428 | Hafenstein et al. (53) | |
Fab A3B10 | 23 | 0, 2, 3, 6 | 85, 87, 231, 232, 233, 296, 297, 299, 300, 301, 302, 303, 390, 391 | Wikoff et al. (129) | |
Erythroparvovirus | |||||
B19 | α-hu 860–55D | 3.2 | I, III, IV, HI-loop | 57–62, 197,198, 200, 256, 274, 278–280, 283, 470, 471, 473 | Sun et al. (122) |
CPV, canine parvovirus; FPV, feline panleukopenia virus; MVM, minute virus of mice.